Back to Search
Start Over
Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis ( EAE) in mice.
- Source :
- Clinical & Experimental Immunology; Dec2012, Vol. 170 Issue 3, p254-265, 12p
- Publication Year :
- 2012
-
Abstract
- The nature of pathogenic mechanisms associated with the development of multiple sclerosis ( MS) have long been debated. However, limited research was conducted to define the interplay between infiltrating lymphocytes and resident cells of the central nervous system ( CNS). Data presented in this report describe a novel role for astrocyte-mediated alterations to myelin oligodendrocyte glycoprotein ( MOG)<subscript>35-55</subscript>-specific lymphocyte responses, elicited during the development of experimental autoimmune encephalitomyelitis ( EAE). In-vitro studies demonstrated that astrocytes inhibited the proliferation and interferon ( IFN)-γ, interleukin ( IL)-4, IL-17 and transforming growth factor ( TGF)-β secretion levels of MOG<subscript>35-55</subscript>-specific lymphocytes, an effect that could be ameliorated by astrocyte IL-27 neutralization. However, when astrocytes were pretreated with IFN-γ, they could promote the proliferation and secretion levels of MOG<subscript>35-55</subscript>-specific lymphocytes, coinciding with apparent expression of major histocompatibility complex ( MHC)-II on astrocytes themselves. Quantitative polymerase chain reaction (q PCR) demonstrated that production of IL-27 in the spinal cord was at its highest during the initial phases. Conversely, production of IFN-γ in the spinal cord was highest during the peak phase. Quantitative analysis of MHC-II expression in the spinal cord showed that there was a positive correlation between MHC-II expression and IFN-γ production. In addition, astrocyte MHC-II expression levels correlated positively with IFN-γ production in the spinal cord. These findings suggested that astrocytes might function as both inhibitors and promoters of EAE. Astrocytes prevented MOG<subscript>35-55</subscript>-specific lymphocyte function by secreting IL-27 during the initial phases of EAE. Then, in the presence of higher IFN-γ levels in the spinal cord, astrocytes were converted into antigen-presenting cells. This conversion might promote the progression of pathological damage and result in a peak of EAE severity. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00099104
- Volume :
- 170
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Clinical & Experimental Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 83005470
- Full Text :
- https://doi.org/10.1111/j.1365-2249.2012.04661.x